Poulvac Procerta HVT-IBD-ND

Authorised

This medicine is authorised for use in the European Union

turkey herpes virus, strain HVT-IBD-ND, expressing the VP2 protein of IBDV and the F protein of NDV, live recombinant

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

• Name of medicine:
  Poulvac Procerta HVT-IBD-ND
• Active substance:
  Live recombinant turkey herpes virus, strain HVT-IBD-ND, expressing the VP2 protein of IBDV and the F protein of NDV
• International non-proprietary name (INN) or common name:
  turkey herpes virus, strain HVT-IBD-ND, expressing the VP2 protein of IBDV and the F protein of NDV, live recombinant
• Anatomical therapeutic chemical veterinary (ATCvet) code:
  QI01AD16

Pharmacotherapeutic group

• Immunologicals for aves
• Live viral vaccines
• avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus

Authorisation details

• EMA product number:
  EMEA/V/C/006306

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Poulvac Procerta HVT-IBD-ND

Adopted Reference Number: EMA/CVMP/442900/2024